| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Kidney Transplantation | 20 | 2021 | 5397 | 1.32 | Why? |
| Graft Rejection | 7 | 2020 | 1766 | 1.11 | Why? |
| Isoantibodies | 3 | 2018 | 134 | 0.97 | Why? |
| Protein Inhibitors of Activated STAT | 2 | 2017 | 30 | 0.81 | Why? |
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2017 | 4 | 0.73 | Why? |
| Transplant Recipients | 6 | 2021 | 4982 | 0.69 | Why? |
| PTEN Phosphohydrolase | 1 | 2017 | 70 | 0.69 | Why? |
| Molecular Chaperones | 1 | 2017 | 124 | 0.64 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2017 | 202 | 0.63 | Why? |
| Respiratory Tract Diseases | 1 | 2020 | 1061 | 0.47 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2017 | 877 | 0.44 | Why? |
| Donor Selection | 4 | 2018 | 804 | 0.42 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.40 | Why? |
| Glomerulosclerosis, Focal Segmental | 2 | 2018 | 104 | 0.34 | Why? |
| Graft Survival | 3 | 2018 | 587 | 0.32 | Why? |
| TOR Serine-Threonine Kinases | 2 | 2019 | 385 | 0.31 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.29 | Why? |
| Organ Transplantation | 4 | 2021 | 2616 | 0.29 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.28 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.27 | Why? |
| Renal Dialysis | 4 | 2021 | 4358 | 0.25 | Why? |
| Living Donors | 2 | 2018 | 652 | 0.24 | Why? |
| Kidney Failure, Chronic | 4 | 2020 | 3222 | 0.24 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 2 | 2017 | 176 | 0.23 | Why? |
| Ergocalciferols | 1 | 2021 | 51 | 0.22 | Why? |
| Calcitriol | 1 | 2021 | 84 | 0.22 | Why? |
| Spain | 10 | 2021 | 15545 | 0.22 | Why? |
| Allografts | 3 | 2018 | 761 | 0.21 | Why? |
| Tissue and Organ Procurement | 2 | 2021 | 1277 | 0.18 | Why? |
| Transmembrane Activator and CAML Interactor Protein | 1 | 2017 | 20 | 0.18 | Why? |
| Calcineurin Inhibitors | 1 | 2019 | 218 | 0.18 | Why? |
| Histocompatibility | 1 | 2018 | 53 | 0.18 | Why? |
| Complement Membrane Attack Complex | 1 | 2018 | 153 | 0.17 | Why? |
| HLA Antigens | 3 | 2018 | 830 | 0.17 | Why? |
| Apolipoprotein A-I | 1 | 2018 | 148 | 0.17 | Why? |
| Central Nervous System Neoplasms | 1 | 2017 | 88 | 0.17 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2017 | 109 | 0.17 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.17 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 78 | 0.17 | Why? |
| Hydrazines | 1 | 2017 | 68 | 0.17 | Why? |
| Nephrectomy | 2 | 2018 | 406 | 0.17 | Why? |
| Histocompatibility Testing | 1 | 2018 | 219 | 0.17 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.16 | Why? |
| Glomerular Filtration Rate | 3 | 2018 | 1262 | 0.16 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Smoking Prevention | 1 | 2017 | 116 | 0.15 | Why? |
| Bone and Bones | 1 | 2018 | 235 | 0.15 | Why? |
| Immunosuppressive Agents | 6 | 2020 | 6331 | 0.15 | Why? |
| Tumor Microenvironment | 1 | 2017 | 264 | 0.15 | Why? |
| Kidney Function Tests | 4 | 2018 | 520 | 0.15 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.15 | Why? |
| Waiting Lists | 2 | 2020 | 1388 | 0.14 | Why? |
| Kidney | 2 | 2020 | 3648 | 0.14 | Why? |
| B-Lymphocytes | 3 | 2018 | 4418 | 0.13 | Why? |
| Nephrology | 1 | 2020 | 546 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2021 | 810 | 0.13 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.13 | Why? |
| Tissue Donors | 3 | 2018 | 1679 | 0.13 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.13 | Why? |
| Patient Education as Topic | 2 | 2020 | 1476 | 0.13 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.12 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.12 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.11 | Why? |
| Aspergillus | 1 | 2014 | 347 | 0.11 | Why? |
| Follow-Up Studies | 5 | 2020 | 17020 | 0.11 | Why? |
| ErbB Receptors | 1 | 2012 | 320 | 0.10 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.10 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.10 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.10 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.09 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.09 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 127 | 0.09 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.09 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
| Renal Insufficiency, Chronic | 2 | 2020 | 2654 | 0.09 | Why? |
| Cytosol | 1 | 2008 | 77 | 0.09 | Why? |
| Gene Expression Regulation, Leukemic | 1 | 2008 | 31 | 0.09 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.09 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.09 | Why? |
| Male | 23 | 2021 | 367725 | 0.09 | Why? |
| Chromosome Deletion | 1 | 2008 | 62 | 0.09 | Why? |
| Drug Resistance, Neoplasm | 1 | 2012 | 447 | 0.09 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.09 | Why? |
| Registries | 4 | 2021 | 12327 | 0.09 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.09 | Why? |
| Female | 22 | 2021 | 380317 | 0.08 | Why? |
| Aged | 13 | 2021 | 215776 | 0.08 | Why? |
| Resource Allocation | 1 | 2018 | 1771 | 0.08 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.08 | Why? |
| Humans | 38 | 2021 | 930598 | 0.08 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2014 | 634 | 0.08 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.08 | Why? |
| Immunocompromised Host | 2 | 2020 | 5150 | 0.08 | Why? |
| Immunologic Memory | 1 | 2018 | 3362 | 0.08 | Why? |
| DNA-Binding Proteins | 1 | 2009 | 469 | 0.08 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.07 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.07 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.07 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.07 | Why? |
| Histones | 1 | 2008 | 371 | 0.07 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.07 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.07 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.06 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| Hyperparathyroidism, Secondary | 1 | 2021 | 47 | 0.06 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.06 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.05 | Why? |
| Antineoplastic Agents | 2 | 2017 | 3550 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.05 | Why? |
| Edetic Acid | 1 | 2020 | 85 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Calcifediol | 1 | 2021 | 191 | 0.05 | Why? |
| Complement Factor H | 1 | 2018 | 83 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Technetium Tc 99m Pentetate | 1 | 2017 | 14 | 0.04 | Why? |
| Colorectal Neoplasms | 1 | 2012 | 1884 | 0.04 | Why? |
| Hemodialysis Units, Hospital | 1 | 2020 | 195 | 0.04 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.04 | Why? |
| Immunoglobulin Class Switching | 1 | 2017 | 133 | 0.04 | Why? |
| Leukopenia | 1 | 2019 | 280 | 0.04 | Why? |
| Mycophenolic Acid | 1 | 2019 | 383 | 0.04 | Why? |
| Apoptosis | 1 | 2008 | 2335 | 0.04 | Why? |
| Delayed Graft Function | 1 | 2017 | 52 | 0.04 | Why? |
| Treatment Outcome | 6 | 2020 | 51732 | 0.04 | Why? |
| Kidney Tubules | 1 | 2018 | 205 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Expert Testimony | 1 | 2020 | 658 | 0.04 | Why? |
| Calcium | 1 | 2021 | 708 | 0.04 | Why? |
| Perfusion | 1 | 2017 | 254 | 0.04 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.04 | Why? |
| Adult | 9 | 2020 | 244371 | 0.04 | Why? |
| Sirolimus | 1 | 2017 | 240 | 0.04 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.04 | Why? |
| Salvage Therapy | 1 | 2017 | 417 | 0.04 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.03 | Why? |
| Mental Disorders | 1 | 2017 | 6742 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Compassionate Use Trials | 1 | 2017 | 632 | 0.03 | Why? |
| Dyslipidemias | 1 | 2019 | 791 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Antibodies, Monoclonal | 1 | 2012 | 8041 | 0.03 | Why? |
| Cetuximab | 1 | 2012 | 35 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Standard of Care | 1 | 2019 | 1297 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Complement Activation | 1 | 2018 | 949 | 0.03 | Why? |
| Cell Line, Tumor | 2 | 2012 | 3608 | 0.03 | Why? |
| Drug Monitoring | 1 | 2019 | 1408 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Quinazolines | 1 | 2012 | 126 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.03 | Why? |
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2009 | 65 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Translocation, Genetic | 1 | 2009 | 40 | 0.02 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.02 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.02 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.02 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2009 | 283 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Chromosome Aberrations | 1 | 2008 | 54 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.02 | Why? |
| Diarrhea | 1 | 2019 | 2743 | 0.02 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.02 | Why? |
| DNA Mutational Analysis | 1 | 2009 | 581 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Germinal Center | 1 | 2009 | 332 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.02 | Why? |
| Occupational Stress | 1 | 2020 | 2044 | 0.02 | Why? |
| Mutation, Missense | 1 | 2012 | 863 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| DNA Damage | 1 | 2008 | 285 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Promoter Regions, Genetic | 1 | 2009 | 823 | 0.02 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.02 | Why? |
| Cell Nucleus | 1 | 2008 | 399 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Early Diagnosis | 1 | 2014 | 2443 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Antifungal Agents | 1 | 2014 | 1828 | 0.02 | Why? |
| Transcription, Genetic | 1 | 2009 | 1326 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 1014 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Epitopes | 1 | 2012 | 4113 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2014 | 9537 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Protein Binding | 1 | 2009 | 11430 | 0.01 | Why? |
| Mutation | 1 | 2009 | 12376 | 0.01 | Why? |